The real-options paradigm serves as a new platform in the evaluation of intellectual capital assets. A prominent case of real-options applications in intellectual capital is R&D investment, since R&D constitutes a major part of a firm's structural capital as well as a major field of realoptions appl
Joint venture evolution: extending the real options approach
โ Scribed by Jing Li; Charles Dhanaraj; Richard L. Shockley
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 297 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0143-6570
- DOI
- 10.1002/mde.1407
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Real options theory has emerged as a promising avenue to study joint venture (JV) evolution as a strategic response to managing uncertainty. We extend the real options approach by integrating it with game theory. Such a combined method enriches the valuation functions of each partnering firm and helps to identify the optimal decisions for exercising options in a JV. In our model, each firm's synergy from the joint operation and its knowledge acquisition capability (KAC) can significantly influence the competitive dynamics between partners, potentially affecting how each firm decides to acquire, divest, or dissolve. We employ a new solution technique in real options theory to capture the stochastic process of three factors, and use computer simulation to test the model under varying conditions. The results are stated in five testable propositions, providing a better understanding of the dynamics of a JV. We find that symmetries between partners in synergy or KAC contribute to stability or dissolution of the JV, whereas asymmetries in synergy or KAC make acquisition of the JV assets by one partner desirable. Copyright ยฉ 2008 John Wiley & Sons, Ltd.
๐ SIMILAR VOLUMES
Foreign investors and their domestic joint venture partners must find ways to share the benefits of the venture if both sides are to be satisfied. Some work in the literature on joint ventures has asserted that there is a danger in all joint ventures, and especially joint ventures with Japanese, tha
Sources of heterogeneity within the process of research and development (R&D) investment, such as international differences in the maximum per-period rate of investment and level of regulatory uncertainty, offer a plausible explanation for US comparative advantage in biotechnology. Using dynamic sto